Restrictive left ventricular filling pattern and its effect on the clinical course of systolic heart failure in patients receiving carvedilol

Cardiology Journal

Volumn 15, Issue 4, 2008, Pages 329-337

  Nessler, Jadwiga ^a,c   Nessler, Bohdan ^a   Kitliński, Mariusz ^b   Stepniewski, Marek ^a   Piwowarska, Wiesława ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b LUND UNIVERSITY   (Sweden)

^c Radioligand Laboratory ^*  (Poland)

Author keywords

Carvedilol; Heart failure; Restrictive filling pattern

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD GAS ANALYSIS; CARDIOPULMONARY EXERCISE TEST; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; OXYGEN CONSUMPTION; PROTEIN BLOOD LEVEL; SYSTOLIC HEART FAILURE; ANALYSIS OF VARIANCE; BLOOD; BLOOD FLOW VELOCITY; CASE CONTROL STUDY; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; ECHOGRAPHY; EXERCISE TOLERANCE; HEART STROKE VOLUME; HOSPITALIZATION; MIDDLE AGED; MITRAL VALVE STENOSIS; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROBABILITY; REFERENCE VALUE; RISK ASSESSMENT; STATISTICAL MODEL; SURVIVAL; TREATMENT OUTCOME;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD FLOW VELOCITY; CARBAZOLES; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TOLERANCE; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; NATRIURETIC PEPTIDE, BRAIN; PROBABILITY; PROPANOLAMINES; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 55249095106     PISSN: 18975593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Banerjee P, Banerjee T, Khand A, Clark AL, Cleland JG. Diastolic heart failure: Neglected or misdiagnosed? J Am Coll Cardiol, 2002; 39: 138-141.
2. Angeja BG, Grossman W. Evaluation and management of diastolic heart failure.Circulation, 2003; 107: 659-663.
3. Brutsaert DL. Diagnosing primary diastolic heart failure. Eur Heart J, 2000; 21: 94-96.
4. Xie GY, Berk MR, Smith MD, Gurley JC, DeMaria AN. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol, 1994; 24: 132-139.
5. Tabet JY, Logeart D, Geyer C et al.Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic heart failure. Eur Heart J, 2000; 21: 1864-1871.
6. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation, 1994; 90: 2772-2779.
7. Capomolla S, Pinna GD, Febo O, Caporotondi A, Guazzotti G, La Rovere MT. Echo-Doppler mitral flow monitoring: An operative tool to evaluate day-to-day tolerance to and effectiveness of beta-adrenergic blocking agent therapy in patients with chronic heart failure. J Am Coll Cardiol, 2001; 38: 1675-1684.
8. Torosoff M, Philbin EF. Improving outcomes in diastolic heart failure. Techniques to evaluate underlying causes and target therapy. Postgrad Med, 2003; 113: 51-58.
9. Ohno M, Cheng CP, Little WC. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation, 1994; 89: 2241-2250.
10. Traversi E, Pozzoli M, Cioffi G et al. Mitral flow velocity changes after 6 months of optimized therapy provide important hemodynamic and prognostic information in patients with chronic heart failure. Am Heart J, 1996; 132: 809-819.
11. Witkowska M. Zaburzenia czynności rozkurczowej serca: Patofiziologia, diagnostyka, leczenie. Wydawnictwo Lekarskie PZWL, Warszawa 2002.
12. Nessler J, Skrzypek A, Piwowarska W. Diastolic dysfunction as a risk factor in patients with heart failure. Przegl Lek, 2004; 61: 962-967.
13. Palazzuoli A, Bruni F, Puccetti L et al. Effects of carvedilol on left ventricular remodeling and systolic function in elderly patients with heart failure. Eur J Heart Fail, 2002; 4: 765-770.
14. Giannuzzi P, Temporelli PL, Bosimini E et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular ysfunction. J Am Coll Cardiol, 1996; 28: 383-390.
15. Pozzoli M, Traversi E, Cioffi G, Stenner R, Sanarico M, Tavazzi L. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation, 1997; 95: 1222-1230.
16. Dhir M, Nagueh SF. Echocardiography and prognosis of heart failure. Curr Opin Cardiol, 2002; 17: 253-256.
17. Pinamonti B, Zecchin M, Di Lenarda A, Gregori D, Sinagra G, Camerini F. Persistence of restrictive left ventricular filling pattern in dilated cardiomyopathy: an ominous prognostic sign. J Am Coll Cardiol, 1997; 29: 604-612.
18. Bergstrom A, Andersson B, Edner M, Nylander E, Persson H, Dahlstrom U. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC). Eur Heart Failure, 2004; 453-461.
19. Capomolla S, Febo O, Gnemmi M et al. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol. Am Heart J, 2000; 139: 596-608.
20. Tang WH, Girod JP, Lee MJ, Starling RC, Young JB, Van Lente F. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation, 2003; 108: 2964-2966.
21. Standardy Echokardiografii Klinicznej Sekcji Echokardiografii Polskiego Towarzystwa Kardiologicznego (www.ptkardio.pl//standardy/haslo/ start_n.html).
22. Kasprzak JD, Wierzbowska-Drabik K, Drozdz J. Ocena czynności lewej komory - funkcja skurczowa i rozkurczowa. In: Podolec P, Tracz W., Hoffman P eds. Echokardiografia praktyczna. Vol. I, Medycyna Praktyczna, Kraków 2004: 135-147.
23. Szwed H. Diagnostyka echokardiograficzna niedokrwiennej przebudowy serca. In: Szyszka A ed. Przebudowa serca. Via Media, Gdańsk 2002: 31-48.
24. Nessler J, Hlawaty M. Projekcje w echokardiografii przezklatkowej. In: Podolec P, Tracz W., Hoffman P eds. Echokardiografia praktyczna. Vol. I. Medycyna Praktyczna, Kraków 2004: 59-73.
25. Hansen A, Haass M, Zugck C et al. Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure. J Am Coll Cardiol, 2001; 37: 1049-1055.
26. Podolec P, Tomkiewicz L, Szcześniak J, Tracz W. The role of cardiopulmonary exercise testing in cardiology. The description of testing procedure and selected parameters needed for evaluation of the cardiopulmonary system function. Przeg Lek, 1998; 55: 57-63.
27. Working Group on Cardiac Rehabilitation & Exercise Physiology and Working Group on Heart Failure of the European Society of Cardiology. Recommendations for exercise testing in chronic heart failure patients. Eur Heart J, 2001; 22: 37-45.
28. Podolec P, Tomkiewicz-Pajak L, Pieculewicz M et al. Reproducibility of spiro-ergometric exercise test parameters in patients with heart failure. Przegl Lek, 2002; 59: 580-582.
29. Yu HC, Sanderson JE. Different prognostic significance of right and left ventricular diastolic dysfunction in heart failure. Clin Cardiol, 1999; 22: 504-512.
30. Rihal CS, Nishimura RA, Hatle LK, Bailey KR, Tajik AJ. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy. Relation to symptoms and prognosis. Circulation, 1994; 90: 2772-2779.
31. Spirto P, Maron BJ, Bonow RO. Noninvasive assessment of left ventricular diastolic function: comparative analysis of Doppler echocardiographic and radionuclide angiographic techniques. J Am Coll Cardiol, 1986; 7: 518-526.
32. Stauffer J, Gaash WH. Recognition and treatment of left ventricular diastolic dysfunction. Prog Cardiovasc Disc, 1990; 32: 319-332.
33. Vanoverschelde J-LJ, Raphael DA, Robert AR, Cosyns JR. Left ventricular filling in dilated cardiomyopathy: Relation to functional class and hemodynamics. J Am Coll Cardiol, 1990; 15: 1288-1295.
34. Vasan R, Benjamin EJ, Levy D. Congestive heart failure with normal left ventricular systolic function. Arch Intern Med, 1996; 156: 146-157.
35. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: An epidemiologic perspective. J Am Coll Cardiol, 1995; 26: 1565-1574.
36. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol, 1990; 65: 903-908.
37. Giannuzzi P, Temporelli PL, Bosimini E et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol, 1996; 28: 383-390.
38. Andersson B, Caidahl K, di Lenarda A et al. Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. Circulation, 1996; 94: 673-682.
39. Moller JE, Hillis GS, Oh JK. Left atrial volume: A powerful predictor of survival after acute myocardial infarction. Circulation, 2003; 107: 2207-2212.
40. Gackowski A, Isnard R, Piwowarska W, Komajda M. B-type natriuretic peptide. New tool in clinical cardiology. Kardiol Pol, 2002; 56: 644-648.
41. Cheung BM, Kumana CR. Natriuretic peptides - relevance in cardiovascular disease. JAMA, 1998; 280: 1983-1984.
42. Cowie MR. BNP: Soon to become a routine measure in the care of patients with heart failure? Heart, 2000; 83: 617-618.
43. Koglin J, Pehlivanli S, Schwaiblmair M, Vogeser M, Cremer P, von Scheidt W. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol, 2001; 38: 1934-1941.
44. Troughton RW, Prior DL, Pereira JJ et al. Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol, 2004; 43: 416-422.
45. Lubien E, DeMaria A, Krishnaswamy P et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: Comparison with Doppler velocity recordings. Circulation, 2002; 105: 595-601.